Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to learn about the safety and efficacy of a potential new treatment called Lenti-HPV-07 in patients with a cancer induced by Human Papilloma Virus (HPV). The main q...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Theravectys S.A.
NCT05307939 · HPV, Oropharynx Cancer, and more
NCT05639972 · HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, and more
NCT06640283 · HPV-Related Carcinoma, Uterine Cervical Cancer, and more
NCT06088381 · Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, and more
NCT04900623 · HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, and more
Florida Cancer Specialists (from Sarah Canon research Institute)
Orlando, Florida
Tampa General Hospital
Tampa, Florida
Moffitt Cancer Center
Tampa, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions